Application Nr Approved Date Route Status External Links
ANDA204511 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications & Usage Levetiracetam Extended-Release Tablets Usp Is Indicated As Adjunctive Therapy In The Treatment Of Partial Onset Seizures In Patients 12 Years Of Age And Older With Epilepsy. Levetiracetam Extended-Release Tablets Usp Is Indicated For Adjunctive Therapy In The Treatment Of Partial Onset Seizures In Patients 12 Years Of Age And Older With Epilepsy

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Levetiracetam LEVETIRACETAM ZINC1547851

Comments